{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:42:25Z","timestamp":1789764145053,"version":"4.0.1"},"reference-count":181,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.psc.2004.07.001","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:20Z","timestamp":1113836000000},"page":"801-825","source":"Crossref","is-referenced-by-count":82,"title":["The neuropsychiatry of Parkinson's disease and related disorders"],"prefix":"10.1016","volume":"27","author":[{"given":"Edward C.","family":"Lauterbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2004.07.001_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson's disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mds.10459","article-title":"Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders","volume":"18","author":"Litvan","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson's disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","article-title":"Comorbidity of the nonmotor symptoms of Parkinson's disease","volume":"16","author":"Shulman","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/BF02339904","article-title":"Differing patterns of psychiatric impairment in Alzheimer and demented Parkinsonian patients","volume":"15","author":"Soliveri","year":"1994","journal-title":"Ital J Neurol Sci"},{"issue":"Suppl 6","key":"10.1016\/j.psc.2004.07.001_bib6","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1212\/WNL.50.6_Suppl_6.S33","article-title":"Managing the neuropsychiatric symptoms of Parkinson's disease","volume":"50","author":"Lieberman","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1212\/WNL.54.8.1596","article-title":"A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease","volume":"54","author":"Hughes","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archneur.59.1.102","article-title":"Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response","volume":"59","author":"Apaydin","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.psc.2004.07.001_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archneur.57.4.470","article-title":"Cognitive impairment and the brain dopaminergic system in Parkinson disease. [18F]fluorodopa positron emission tomographic study","volume":"57","author":"Rinne","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awf134","article-title":"Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[(18)F]fluoro-L-dopa PET study","volume":"125","author":"Ito","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/brain\/123.2.340","article-title":"Cortical dysfunction in nondemented Parkinson's disease patients. A combined 31P-MRS and 18FDG-PET study","volume":"123","author":"Hu","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib14","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/jnnp.72.6.708","article-title":"Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study","volume":"72","author":"Aarsland","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.993","article-title":"Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease","volume":"19","author":"Leroi","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1006\/brcg.1999.1083","article-title":"Acute and long-term administration of anticholinergics in Parkinson's disease: specific effects on the subcortico\u2013frontal syndrome","volume":"40","author":"Bedard","year":"1999","journal-title":"Brain Cogn"},{"key":"10.1016\/j.psc.2004.07.001_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00702-002-0811-7","article-title":"Pramipexole in comparison to L-DOPA: a neuropsychological study","volume":"110","author":"Brusa","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.psc.2004.07.001_bib18","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/brain\/awf046","article-title":"Global attentional\u2013executive sequelae following surgical lesions to globus pallidus interna","volume":"125","author":"Scott","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/brcg.1999.1109","article-title":"Impaired frontostriatal cognitive functioning following posteroventral pallidotomy in advanced Parkinson's disease","volume":"42","author":"Stebbins","year":"2000","journal-title":"Brain Cogn"},{"key":"10.1016\/j.psc.2004.07.001_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1006\/brcg.1999.1110","article-title":"Neuropsychological outcome following unilateral stereotactic pallidotomy in intractable Parkinson's disease","volume":"42","author":"Lacritz","year":"2000","journal-title":"Brain Cogn"},{"key":"10.1016\/j.psc.2004.07.001_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3171\/jns.2003.99.1.0078","article-title":"A waitlist control-group study of cognitive, mood, and quality of life outcome after posteroventral pallidotomy in Parkinson's disease","volume":"99","author":"Carr","year":"2003","journal-title":"J Neurosurg"},{"key":"10.1016\/j.psc.2004.07.001_bib22","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/brain\/123.10.2091","article-title":"Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease","volume":"123","author":"Saint-Cyr","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib23","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s004150170139","article-title":"Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease","volume":"248","author":"Dujardin","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00019052-200108000-00011","article-title":"Management of psychosis in Parkinson's disease","volume":"14","author":"Wolters","year":"2001","journal-title":"Curr Opin Neurol"},{"issue":"Suppl 3","key":"10.1016\/j.psc.2004.07.001_bib25","doi-asserted-by":"crossref","first-page":"III28","DOI":"10.1007\/PL00007823","article-title":"Drug-induced psychotic symptoms in Parkinson's disease. Problems, management, and dilemma","volume":"248","author":"Kuzuhara","year":"2001","journal-title":"J Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib26","first-page":"115","article-title":"Parkinson's disease: drug-induced psychiatric states","volume":"65","author":"Factor","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib27","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.1991.tb03627.x","article-title":"Behavioral complications of drug treatment of Parkinson's disease","volume":"39","author":"Cummings","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.psc.2004.07.001_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease. Prevalence, phenomenology, and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"issue":"Suppl 4","key":"10.1016\/j.psc.2004.07.001_bib29","first-page":"S120","article-title":"Drugs to treat dementia and psychosis","volume":"17","author":"Movement Disorder Society","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/jnnp.70.6.727","article-title":"Visual hallucinations in Parkinson's disease: a review and phenomenological survey","volume":"70","author":"Barnes","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","article-title":"Prospective study of hallucinations and delusions in Parkinson's disease","volume":"70","author":"Holroyd","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib32","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Prospective longitudinal assessment of hallucinations in Parkinson's disease","volume":"57","author":"Goetz","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib33","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.58.10.1546","article-title":"Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease","volume":"58","author":"Romito","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1531-8257(200003)15:2<201::AID-MDS1001>3.0.CO;2-D","article-title":"Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease","volume":"15","author":"Friedman","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib35","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"340","author":"The Parkinson Study Group","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.psc.2004.07.001_bib36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(99)00860-0","article-title":"Clozapine in drug-induced psychosis in Parkinson's disease","volume":"353","author":"The French Clozapine Parkinson Study Group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2004.07.001_bib37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1212\/WNL.55.6.789","article-title":"Olanzapine and clozapine. Comparative effects on motor function in hallucinating PD patients","volume":"55","author":"Goetz","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/mds.10217","article-title":"Olanzapine treatment for dopaminergic-induced hallucinations","volume":"17","author":"Ondo","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0006-3223(02)01392-6","article-title":"Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease","volume":"52","author":"Breier","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/089198879500800204","article-title":"Anticholinergic effects in a depressed Parkinsonian patient","volume":"8","author":"Huszonek","year":"1995","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib41","first-page":"93","article-title":"On\u2013off phenomena and manic\u2013depressive mood shifts: case report","volume":"47","author":"Keshavan","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib42","first-page":"557","article-title":"Disappearance of akinesia in Parkinson's disease during a manic attack","volume":"149","author":"Larmande","year":"1993","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.psc.2004.07.001_bib43","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1006\/brcg.1999.1113","article-title":"The behavioral complications of pallidal stimulation: a case report","volume":"42","author":"Miyawaki","year":"2000","journal-title":"Brain Cogn"},{"key":"10.1016\/j.psc.2004.07.001_bib44","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mds.10265","article-title":"Transient mania with hypersexuality after surgery for high-frequency stimulation of the subthalamic nucleus in Parkinson's disease","volume":"17","author":"Romito","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/jnp.6.2.181","article-title":"Treatment of organic bipolar mood disorders in Parkinson's disease","volume":"6","author":"Kim","year":"1994","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib46","first-page":"676","article-title":"Neuropsychiatric disorders in Parkinson's disease","volume":"32","author":"Noe Sebastian","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10010","article-title":"Factors impacting on quality of life in Parkinson's disease: results from an international survey","volume":"17","author":"Global Parkinson's Disease Survey Steering Committee","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease. A community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson's disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/089198870101400304","article-title":"Are patients with Parkinson's disease suicidal?","volume":"14","author":"Myslobodsky","year":"2001","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib51","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/mds.10198","article-title":"Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease","volume":"17","author":"Doshi","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mds.870130109","article-title":"Depression in classic versus akinetic\u2013rigid Parkinson's disease","volume":"13","author":"Starkstein","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00005053-199001000-00005","article-title":"Depression in Parkinson's disease","volume":"178","author":"Starkstein","year":"1990","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.psc.2004.07.001_bib54","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/jnp.8.1.20","article-title":"Depression and disability in Parkinson's disease","volume":"8","author":"Cole","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s004150050131","article-title":"The correlation of depression with functional activity in Parkinson's disease","volume":"244","author":"Liu","year":"1997","journal-title":"J Neurol"},{"issue":"Suppl 5","key":"10.1016\/j.psc.2004.07.001_bib56","first-page":"223","article-title":"Differential correlates of mood and cognition in dystonia and Parkinson's disease","volume":"17","author":"Lauterbach","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib57","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1176\/jnp.9.2.259","article-title":"Clinical, motor, and biological correlates of depressive disorders after focal subcortical lesions","volume":"9","author":"Lauterbach","year":"1997","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib58","first-page":"9","article-title":"Major depression after left posterior globus pallidus lesions","volume":"10","author":"Lauterbach","year":"1997","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00002826-200107000-00005","article-title":"SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study","volume":"24","author":"Dell'Agnello","year":"2001","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 4","key":"10.1016\/j.psc.2004.07.001_bib60","first-page":"S112","article-title":"Treatment of depression in idiopathic Parkinson's disease","volume":"17","author":"Movement Disorder Society","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib61","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0404.1980.tb03028.x","article-title":"Antidepressive treatment in Parkinson's disease: a controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA","volume":"62","author":"Andersen","year":"1980","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.psc.2004.07.001_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/jnp.10.2.187","article-title":"Effectiveness of ECT in patients with parkinsonism","volume":"10","author":"Moellentine","year":"1998","journal-title":"J Neuropsychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib63","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","article-title":"Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity","volume":"59","author":"Okun","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib64","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/ajp.147.2.217","article-title":"Anxiety disorders in patients with Parkinson's disease","volume":"147","author":"Stein","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-3223(93)90237-8","article-title":"Parkinson's disease and anxiety: comorbidity with depression","volume":"34","author":"Menza","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.870080415","article-title":"Anxiety and motor performance in Parkinson's disease","volume":"8","author":"Siemers","year":"1993","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib67","first-page":"326","article-title":"Treatment of anxiety in Parkinson's disease with bromazepam","volume":"45","author":"Casacchia","year":"1975","journal-title":"Rev Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib68","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00002826-199402000-00008","article-title":"Buspirone in levodopa-induced dyskinesias","volume":"17","author":"Bonifati","year":"1994","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psc.2004.07.001_bib69","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"Panic attacks in Parkinson's disease. A long-term complication of levodopa therapy","volume":"87","author":"Vazquez","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.psc.2004.07.001_bib70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00146965-200312000-00004","article-title":"Correlates of generalized anxiety and panic attacks in dystonia and Parkinson's disease","volume":"16","author":"Lauterbach","year":"2003","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib71","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/appi.neuropsych.16.1.29","article-title":"Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease","volume":"16","author":"Lauterbach","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.psc.2004.07.001_bib72","first-page":"267","article-title":"Neuropsychiatric correlates of familial Parkinsonism","volume":"37","author":"Lauterbach","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib73","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1017418","article-title":"Levodopa dependence: a case report","volume":"17","author":"Priebe","year":"1984","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib74","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/j.1875-9114.1997.tb03794.x","article-title":"Levodopa dependence and abuse in Parkinson's disease","volume":"17","author":"Spigset","year":"1997","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psc.2004.07.001_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1532-5415.1977.tb00415.x","article-title":"Increased appetite (bulimia) in Parkinson's disease","volume":"25","author":"Rosenberg","year":"1977","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.psc.2004.07.001_bib76","first-page":"107","article-title":"Sleep dysfunction in Parkinson's disease","volume":"5","author":"Trenkwalder","year":"1998","journal-title":"Clin Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00023210-200115040-00002","article-title":"Sleep disorders in patients with Parkinson's disease: epidemiology and management","volume":"15","author":"Larsen","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2004.07.001_bib78","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.10167","article-title":"Sleep disorders in Parkinson's disease","volume":"17","author":"Kumar","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib79","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/mds.10390","article-title":"Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease","volume":"18","author":"Adler","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib80","first-page":"905","article-title":"Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial","volume":"25","author":"Hogl","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.psc.2004.07.001_bib81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1566-0702(01)00295-8","article-title":"Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease","volume":"92","author":"Sakakibara","year":"2001","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib82","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib83","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W","article-title":"Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease","volume":"15","author":"Zesiewicz","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib84","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00002826-200207000-00008","article-title":"Reversible transvestic fetishism in a man with Parkinson's disease treated with selegiline","volume":"25","author":"Riley","year":"2002","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psc.2004.07.001_bib85","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/PL00007840","article-title":"Penile erections and hypersexuality induced by pergolide treatment in advanced, fluctuating Parkinson's disease","volume":"249","author":"Kanovsky","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib86","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/mds.870130326","article-title":"Apomorphine-induced penile erections in Parkinson's disease","volume":"13","author":"O'Sullivan","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib87","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00002826-199704000-00005","article-title":"Psychiatric and sexual disorders induced by apomorphine in Parkinson's disease","volume":"20","author":"Courty","year":"1997","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psc.2004.07.001_bib88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.870130338","article-title":"Clozapine for dopaminergic-induced paraphilias in Parkinson's disease","volume":"13","author":"Fernandez","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib89","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/WNL.47.5.1113","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"47","author":"McKeith","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072807","article-title":"Systematic review and meta-analysis show that dementia with Lewy bodies is a visual\u2013perceptual and attentional\u2013executive dementia","volume":"16","author":"Collerton","year":"2003","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib91","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1563-258x.2002.01129.x","article-title":"Dementia with Lewy bodies","volume":"152","author":"Ransmayr","year":"2002","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.psc.2004.07.001_bib92","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1212\/WNL.54.9.1780","article-title":"Severity of cognitive impairment and the clinical diagnosis of AD with Lewy bodies","volume":"54","author":"Lopez","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1099-1166(200001)15:1<40::AID-GPS74>3.0.CO;2-S","article-title":"Clinical Lewy body dementia and the impact of vascular components","volume":"15","author":"Londos","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib94","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/appi.ajp.161.5.843","article-title":"Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies","volume":"161","author":"Ballard","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1176\/appi.neuropsych.12.4.425","article-title":"A review of the cognitive and behavioral symptoms in dementia with Lewy bodies","volume":"12","author":"Simard","year":"2000","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2004.07.001_bib96","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-510X(03)00220-X","article-title":"Cognitive conditions of pathologically confirmed dementia with Lewy bodies and Parkinson's disease with dementia","volume":"216","author":"Horimoto","year":"2003","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.psc.2004.07.001_bib97","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003672","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies","author":"Wild","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2004.07.001_bib98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with Lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system","volume":"13","author":"Wesnes","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib99","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000017260","article-title":"Acetylcholinesterase inhibition in dementia with Lewy bodies: results of a prospective pilot trial","volume":"11","author":"Querfurth","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/gps.389","article-title":"A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia","volume":"16","author":"Aarsland","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib101","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib102","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomized, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2004.07.001_bib103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S104161020100758X","article-title":"Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial","volume":"13","author":"Grace","year":"2001","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.psc.2004.07.001_bib104","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","article-title":"Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","volume":"15","author":"Samuel","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib105","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4088\/JCP.v63n0608","article-title":"Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies","volume":"63","author":"Fernandez","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib106","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0278-5846(03)00040-X","article-title":"Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series","volume":"27","author":"Takahashi","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000048636","article-title":"Efficacy of olanzapine in the treatment of psychosis in dementia with lewy bodies","volume":"13","author":"Cummings","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib108","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/scnp.2003.50006","article-title":"Dementia with Lewy bodies","volume":"8","author":"McKeith","year":"2003","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib109","first-page":"55","article-title":"Depression in autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease","volume":"71","author":"Samuels","year":"2004","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.psc.2004.07.001_bib110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00124509-200306000-00009","article-title":"Electroconvulsive therapy for patients with major depression and probable Lewy body dementia","volume":"19","author":"Rasmussen","year":"2003","journal-title":"J ECT"},{"key":"10.1016\/j.psc.2004.07.001_bib111","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/1099-1166(200011)15:11<1028::AID-GPS227>3.0.CO;2-E","article-title":"A comparison of sleep profiles in patients with dementia with Lewy bodies and Alzheimer's disease","volume":"15","author":"Grace","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib112","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mds.1120","article-title":"Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy","volume":"16","author":"Boeve","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib113","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/brain\/awf117","article-title":"Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients","volume":"125","author":"Watanabe","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib114","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2004.07.001_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/jnnp.52.Suppl.78","article-title":"Multiple system atrophy: the nature of the beast","volume":"June Suppl","author":"Quinn","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib116","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.psc.2004.07.001_bib117","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib118","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/WNL.47.5.1291","article-title":"Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy","volume":"47","author":"Ito","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib119","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS in patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.psc.2004.07.001_bib120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.ijir.3901014","article-title":"Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study","volume":"15","author":"Kirchhof","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.psc.2004.07.001_bib121","first-page":"842","article-title":"REM sleep behavior disorders in multiple system atrophy","volume":"14","author":"Plazzi","year":"1999","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/01.WNL.0000073745.68744.94","article-title":"REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA","volume":"61","author":"Gilman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib123","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s007020050050","article-title":"Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy","volume":"105","author":"Litvan","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.psc.2004.07.001_bib124","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","article-title":"What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study","volume":"54","author":"Litvan","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/mds.870100310","article-title":"Pure striatonigral degeneration and Parkinson's disease. A comparative clinical study","volume":"10","author":"Gouider-Khouja","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib126","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archneur.1995.00540270090024","article-title":"Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease","volume":"52","author":"Colosimo","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib127","first-page":"93","article-title":"Magnetic resonance imaging in progressive supranuclear palsy and other Parkinsonian disorders","volume":"42","author":"Savoiardo","year":"1994","journal-title":"J Neurol Transm"},{"key":"10.1016\/j.psc.2004.07.001_bib128","first-page":"1031","article-title":"Clinico-MRI study of hemispheric disorder in long-term follow-up cases of multiple system atrophy","volume":"38","author":"Konagaya","year":"1998","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.psc.2004.07.001_bib129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp.58.2.174","article-title":"Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy","volume":"58","author":"Pillon","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0028-3932(93)90048-5","article-title":"Cognitive and motor performance in multiple system atrophy and Parkinson's disease compared","volume":"31","author":"Testa","year":"1993","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.psc.2004.07.001_bib131","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/jnnp.60.4.393","article-title":"Attentional functions in multiple system atrophy and Parkinson's disease","volume":"60","author":"Meco","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib132","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/jnnp.69.3.313","article-title":"Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multi-system atrophy, and progressive supranuclear palsy","volume":"69","author":"Soliveri","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib133","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archneur.1960.03840110025004","article-title":"A neurological syndrome associated with orthostatic hypotension: a clinical\u2013pathological study","volume":"2","author":"Shy","year":"1960","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib134","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1212\/WNL.40.4.677","article-title":"Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic falure","volume":"40","author":"Munschauer","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib135","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1212\/WNL.54.4.963","article-title":"Involvement of the ventrolateral medulla in parkinsonism with autonomic failure","volume":"54","author":"Benarroch","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib136","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jnnp.44.4.347","article-title":"The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome)","volume":"44","author":"Lees","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib137","first-page":"137","article-title":"Shy-Drager syndrome presenting as depression: case report","volume":"45","author":"Kwentus","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib138","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-5347(17)35246-1","article-title":"Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases","volume":"151","author":"Beck","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.psc.2004.07.001_bib139","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0004-282X1990000200018","article-title":"Shy-Drager syndrome: a case report with polysomnography","volume":"48","author":"Aloe","year":"1990","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.psc.2004.07.001_bib140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/089198879000300210","article-title":"Shy-Drager syndrome presenting as a REM behavioral disorder","volume":"3","author":"Wright","year":"1990","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib141","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp.48.12.1240","article-title":"Respiration and sleep in Parkinson's disease","volume":"48","author":"Apps","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib142","first-page":"370","article-title":"Atrophie olivo-ponto-c\u00e9r\u00e9belleuse","volume":"330","author":"Dejerine","year":"1900","journal-title":"Nouv Iconogr Salp\u00eat"},{"key":"10.1016\/j.psc.2004.07.001_bib143","series-title":"Parkinson's Disease and movement disorders","first-page":"263","article-title":"Olivopontocerebellar atrophy","author":"Berciano","year":"1998"},{"key":"10.1016\/j.psc.2004.07.001_bib144","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00314728","article-title":"Characteristics of oculomotility disorders of a family with Joseph's disease","volume":"237","author":"Shimizu","year":"1990","journal-title":"J Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0303-8467(97)00604-5","article-title":"Cerebellar ataxia, dementia, pyramidal signs, cortical cataract of the posterior pole and a raised IgG index in a patient with a sporadic form of olivopontocerebellar atrophy","volume":"99","author":"Schelhaas","year":"1997","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.psc.2004.07.001_bib146","first-page":"235","article-title":"Striatonigral degeneration combined with olivopontocerebellar atrophy with subcortical dementia and hallucinatory state","volume":"6","author":"Fukutani","year":"1995","journal-title":"Dementia"},{"key":"10.1016\/j.psc.2004.07.001_bib147","first-page":"510","article-title":"Cerebral multisystem atrophy in a patient with depressive hallucinatory syndrome. A case report","volume":"63","author":"Ziegler","year":"1992","journal-title":"Nervenarzt"},{"key":"10.1016\/j.psc.2004.07.001_bib148","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0006-3223(95)00232-4","article-title":"Depression in multiple system atrophy and in idiopathic Parkinson's disease: a pilot comparative study","volume":"39","author":"Pilo","year":"1996","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib149","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2190\/PNR2-PW5Y-KF07-H5BE","article-title":"Psychiatric manifestations of olivo-ponto-cerebellar atrophy and treatment with clozapine","volume":"23","author":"Parsa","year":"1993","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.psc.2004.07.001_bib150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0022-510X(95)00119-M","article-title":"REM sleep without atonia at early stage of sporadic olivopontocerebellar atrophy","volume":"132","author":"Tachibana","year":"1995","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.psc.2004.07.001_bib151","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","article-title":"Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination","volume":"64","author":"Wenning","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib152","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1212\/WNL.46.4.922","article-title":"Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)","volume":"46","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib154","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.54.3.697","article-title":"Differentiation of atypical parkinsonian syndromes with routine MRI","volume":"54","author":"Schrag","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib155","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0033-3182(95)71610-3","article-title":"Psychiatric symptoms in progressive supranuclear palsy","volume":"36","author":"Menza","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psc.2004.07.001_bib156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0404.2001.103002123.x","article-title":"Donepezil in the treatment of progressive supranuclear palsy","volume":"103","author":"Fabbrini","year":"2001","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.psc.2004.07.001_bib157","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1212\/WNL.57.3.467","article-title":"Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy","volume":"57","author":"Litvan","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib158","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib159","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.47.5.1184","article-title":"Neuropsychiatric aspects of progressive supranuclear palsy","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.33588\/rn.3211.2000159","article-title":"Dementia in progressive supranuclear paralysis patients","volume":"32","author":"Barquero-Jimenez","year":"2001","journal-title":"Rev Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib161","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/pgmj.72.847.293","article-title":"Nocturnal and respiratory disturbances in Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)","volume":"72","author":"De Bruin","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.psc.2004.07.001_bib162","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ana.410250609","article-title":"Sleep abnormalities in progressive supranuclear palsy","volume":"25","author":"Aldrich","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib163","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","article-title":"Cortical-basal ganglionic degeneration","volume":"40","author":"Riley","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib164","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-2001-13119","article-title":"Corticobasal degeneration","volume":"21","author":"Stover","year":"2001","journal-title":"Semin Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib165","first-page":"53","article-title":"Epidemiologic aspects","volume":"82","author":"Togasaki","year":"2000","journal-title":"Adv Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib166","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","article-title":"Corticodentatonigral degeneration with neuronal achromasia","volume":"18","author":"Rebeiz","year":"1968","journal-title":"Arch Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib167","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1212\/WNL.46.3.720","article-title":"Neuropsychological functioning in cortico\u2013basal ganglionic degeneration. Differentiation from Alzheimer's disease","volume":"36","author":"Massman","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib168","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/brain\/112.5.1171","article-title":"Corticobasal degeneration","volume":"112","author":"Gibb","year":"1989","journal-title":"Brain"},{"key":"10.1016\/j.psc.2004.07.001_bib169","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/jnnp.57.4.455","article-title":"The nature of apraxia in corticobasal degeneration","volume":"57","author":"Leiguarda","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib170","first-page":"781","article-title":"A case of corticobasal degeneration of which movemental disturbances were improved by administration of amantadine","volume":"53","author":"Yasuoka","year":"2001","journal-title":"No To Shinkei"},{"key":"10.1016\/j.psc.2004.07.001_bib171","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1212\/WNL.41.6.882","article-title":"Primary progressive aphasia with focal neuronal achromasia","volume":"41","author":"Lippa","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.psc.2004.07.001_bib172","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/mds.10536","article-title":"Corticobasal degeneration as a cognitive disorder","volume":"18","author":"Graham","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib173","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00127893-199903000-00001","article-title":"Pick's disease: an introduction and review of the literature","volume":"5","author":"Cherrier","year":"1999","journal-title":"Neurologist"},{"key":"10.1016\/j.psc.2004.07.001_bib174","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/1531-8249(199906)45:6<704::AID-ANA4>3.0.CO;2-X","article-title":"From genotype to phenotype: a clinical, pathological, and biochemical investigation of frontotemporal dementia and Parkinsonism (FTDP-17) caused by the P301L tau mutation","volume":"45","author":"Nasreddine","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib175","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/jnnp.65.5.717","article-title":"Neuropsychiatric features of corticobasal degeneration","volume":"65","author":"Litvan","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.psc.2004.07.001_bib176","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/mds.1227","article-title":"Unilateral periodic limb movements during sleep in corticobasal degeneration","volume":"16","author":"Iriarte","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.psc.2004.07.001_bib177","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/sleep\/20.10.891","article-title":"Subclinical REM sleep behavior disorder in a patient with cortico\u2013basal degeneration","volume":"20","author":"Kimura","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.psc.2004.07.001_bib178","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/ana.410430617","article-title":"Tau is a candidate gene for chromosome 17 frontotemporal dementia","volume":"43","author":"Poorkaj","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.psc.2004.07.001_bib179","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0197-4580(00)00202-5","article-title":"Phenotypic correlations in FTDP-17","volume":"22","author":"Reed","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.psc.2004.07.001_bib180","unstructured":"Wszolek ZK. Familial tauopathies. Clinical considerations. Presented at the 7th International Congress of Parkinson's Disease and Movement Disorders. Miami (FL) November 12, 2002."},{"key":"10.1016\/j.psc.2004.07.001_bib181","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00415-002-0687-3","article-title":"Contrasting genotypes of the tau gene in two phenotypically distinct patients with P301L mutation of frontotemporal dementia and Parkinsonism linked to chromosome 17","volume":"249","author":"Kobayashi","year":"2002","journal-title":"J Neurol"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X04000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X04000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T19:06:14Z","timestamp":1735671974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X04000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":181,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0193953X04000620"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2004.07.001","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}